HIV Latency and the noncoding RNA therapeutic landscape.

Area of Science:

• Virology
• Molecular Biology
• Immunology

Background:

• Human Immunodeficiency Virus (HIV) establishes chronic infection by integrating into CD4+ cells, leading to Acquired Immunodeficiency Syndrome (AIDS).
• Viral latency, a transcriptionally silent state in a subpopulation of infected cells, creates a persistent reservoir, hindering complete eradication.
• Latent HIV reservoirs are a major obstacle to curative therapies.

Purpose of the Study:

• To explore the role of noncoding RNAs in Human Immunodeficiency Virus (HIV) infection.
• To investigate the involvement of noncoding RNAs in the establishment and maintenance of viral latency.
• To examine RNA-based therapeutic strategies for countering HIV infection and regulating viral latency.

Main Methods:

• Review of existing literature on noncoding RNAs and HIV.
• Analysis of the mechanisms by which short and long noncoding RNAs modulate epigenetic regulation and gene expression.
• Exploration of therapeutic modalities targeting RNA in HIV infection.

Main Results:

• Noncoding RNAs are identified as key endogenous modulators of epigenetic regulation in human cells.
• Both short and long noncoding RNAs actively influence gene expression relevant to HIV infection.
• RNA-based therapeutics show potential in controlling HIV replication and latency.

Conclusions:

• Noncoding RNAs are integral to the pathogenesis of HIV infection and the persistence of viral reservoirs.
• Targeting noncoding RNAs presents a promising avenue for novel therapeutic interventions against HIV.
• Further research into RNA-based strategies could lead to effective treatments for HIV and AIDS.